Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Bausch plus Lomb Corporation

BLCO
17,74
-0,26 (-1,44%)
04 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/1/202513:00BWBausch + Lomb to Participate in the 43rd Annual J.P. Morgan..
26/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202413:00BWBausch + Lomb Responds to Rumors of a Potential Sale
11/12/202412:59BWBausch + Lomb Acquires Elios Vision, Significantly Enhances..
14/11/202413:00BWBausch + Lomb Reports More Than 94 Million Units of Contact..
01/11/202421:27EDGAR2Form 8-K - Current report
30/10/202421:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202412:04EDGAR2Form 8-K - Current report
30/10/202412:00BWBausch + Lomb Announces Third-Quarter 2024 Results
14/10/202413:00BWBausch + Lomb Receives FDA Approval for enVista® Envy™ Full..
09/10/202414:00BWBausch + Lomb Will Release Third-Quarter 2024 Financial..
01/10/202413:00BWBausch + Lomb Launches Opal™ Digital Marketplace in the..
17/9/202412:42IHMARKETNEWSInvestors Anticipate Retail Sales Data and Fed Decision; Oil..
06/8/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/8/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202413:06EDGAR2Form 8-K - Current report
31/7/202413:00BWBausch + Lomb Announces Second-Quarter 2024 Results
30/7/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202418:05BWBausch + Lomb Will Release Second-Quarter 2024 Financial..
08/7/202413:00BWMillions of Americans Experience Dry Eye Symptoms, Yet New..
18/6/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:00BWBausch + Lomb Announces Presentation of New Data at the..
10/6/202413:00BWBausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel..
03/6/202413:00BWBausch + Lomb Launches Blink™ NutriTears® Clinically Proven..
29/5/202422:44EDGAR2Form 8-K - Current report
29/5/202422:30BWBausch + Lomb Announces 2024 Annual Meeting of Shareholder..
28/5/202415:00BWBausch + Lomb Announces Presentation of New Scientific Data..
28/5/202412:59BWBausch + Lomb Receives Health Canada Approval for enVista®..
07/5/202415:09IHMARKETNEWSFutures Pointing To Roughly Flat Open On Wall Street
06/5/202422:34IHMARKETNEWSU.S. Stocks See Further Upside Amid Renewed Interest Rate..
01/5/202412:58BWBausch + Lomb Announces First-Quarter 2024 Results
29/4/202413:00BWBausch + Lomb Announces Presentation of New Data at the..
25/4/202414:30BWBausch + Lomb Announces Statistically Significant Results..
18/4/202413:00BWBausch + Lomb Reports More Than 84 Million Units of Contact..
15/4/202418:00BWBausch + Lomb Will Release First-Quarter 2024 Financial..
27/3/202412:00BWBausch + Lomb Will Present New Scientific Data and Analyses..
04/3/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202414:12EDGAR2Form 8-K - Current report
28/2/202414:00BWBausch + Lomb Announces Appointment of Karen L. Ling to..
Apertura: 18,05 Min: 17,72 Max: 18,10
Chiusura: 18,00

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network